Arshia Ghaffari, DO, MA, MBA
|
| Title(s) | Clinical Associate Professor of Medicine (Clinician Educator) |
|---|
| School | Keck School of Medicine of Usc |
|---|
| Address | 2020 Zonal Ave.
Off Campus
Los Angeles CA 90033
|
|---|
| vCard | Download vCard |
|---|
|
|
| Title(s) | Director, USC+DaVita Dialysis Center |
|---|
|
|---|
| Title(s) | Associate Chief, Clinical Affairs, Nephrology and Hypertension |
|---|
|
|---|
|
Biography
| American Society of Nephrology | 2006 | | Travel Grant, Advances in Research Conference- Stem Cells in Organ Maintenance and Repair |
| Physician Leadership Meeting | 2012 | | DaVita Core Value Award for Continuous Quality Improvement |
| Chicago College of Osteopathic Medicine | | | Dr. Lowell Goldberg Memorial Scholarship for Leadership |
Overview
In 2008, after several years of practicing in the Division of Geriatric, Hospital and General Internal Medicine at LAC+USC Medical Center, Dr. Ghaffari joined the Division of Nephrology and Hypertension. Dr. Ghaffari, a native of Iran who grew up in Santa Monica, came to the Keck School of Medicine after years of studying at UC San Diego, Boston University and the Chicago College of Osteopathic Medicine. In addition to speaking English and Farsi, Dr. Ghaffari is also fluent in Spanish. He is a member of several prestigious societies, including the American Osteopathic Association, the American Medical Association and the American College of Physicians.
Along with his academic and clinical duties, Dr. Ghaffari is also an avid researcher, currently examining areas related to chronic kidney disease and end-stage renal disease. In 2007, he was a distinguished lecturer presenting on the rapid determination of caramylated hemoglobin at the Renal Week Meetings in Chicago. Prior to obtaining a Doctorate of Osteopathic Medicine, Dr. Ghaffari has also earned graduate degrees in the fields of Medical Sciences and Health Care Management.
Dr. Ghaffari's clinical areas of expertise:
ADVANCED KIDNEY DISEASES CLINIC
Dr. Ghaffari is recognized as an expert in the management of advanced kidney dysfunction with a goal to preserve kidney function and allow a smooth transition to dialysis at the appropriate time. He is focused on maintaining renal function utilizing all medical and non-medical means including diet, exercise and avoidance of exposures that would promote progression of kidney disease. Dr. Ghaffari is Director of the USC dialysis program and is an avid researcher in the field of peritoneal dialysis.
KIDNEY STONE/ELECTROLYTE CLINIC
Dr. Ghaffari developed an interest in kidney stone and electrolyte disorders during his fellowship training at the University of Illinois in Chicago. He is focused on preventing recurrent kidney stones by focusing on diet along with traditional and non-traditional treatments. He is the lead educator about medical management of kidney stones in the nephrology fellowship program.
POST-ACUTE KIDNEY INJURY CLINIC
Dr. Ghaffari’s expertise includes the management of acute kidney dysfunction and facilitation of kidney recovery in the intensive care unit. He provides close follow-up and management advice for such patients in the outpatient setting.
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2022 06; 17(6):861-871.
Lambie M, Zhao J, McCullough K, Davies SJ, Kawanishi H, Johnson DW, Sloand JA, Sanabria M, Kanjanabuch T, Kim YL, Shen JI, Pisoni RL, Robinson BM, Perl J, PDOPPS Steering Committee. PMID: 35641246; PMCID: PMC9269666.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Peritoneal Dialysis Should Be Considered the First Option for Patients Requiring Urgent Start Dialysis: PRO. Kidney360. 2023 02 01; 4(2):134-137.
Ghaffari A, Doria Medina Sanchez J. PMID: 36821604; PMCID: PMC10103293.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Urgent-start peritoneal dialysis: Association with outcomes. Perit Dial Int. 2023 03; 43(2):186-189.
Karpinski S, Sibbel S, Cohen DE, Colson C, Van Wyck DB, Ghaffari A, Schreiber MJ, Brunelli SM, Tentori F. PMID: 35272530.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis. Kidney Int. 2021 11; 100(5):1101-1111.
Mehrotra R, Stanaway IB, Jarvik GP, Lambie M, Morelle J, Perl J, Himmelfarb J, Heimburger O, Johnson DW, Imam TH, Robinson B, Stenvinkel P, Devuyst O, Davies SJ, Bio-PD Consortium. PMID: 34197840; PMCID: PMC8545920.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak. Adv Chronic Kidney Dis. 2020 09; 27(5):390-396.
Truong T, Dittmar M, Ghaffari A, Lin E. PMID: 33308504; PMCID: PMC7311906.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansCells
-
Attitudes toward Peritoneal Dialysis among Peritoneal Dialysis and Hemodialysis Medical Directors: Are We Preaching to the Right Choir? Clin J Am Soc Nephrol. 2019 07 05; 14(7):1067-1070.
Shen JI, Schreiber MJ, Zhao J, Robinson BM, Pisoni RL, Mehrotra R, Oliver MJ, Tomo T, Tungsanga K, Teitelbaum I, Ghaffari A, Lambie M, Perl J. PMID: 31278114; PMCID: PMC6625627.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Economic evaluation of urgent-start peritoneal dialysis versus urgent-start hemodialysis in the United States. Medicine (Baltimore). 2014 Dec; 93(28):e293.
Liu FX, Ghaffari A, Dhatt H, Kumar V, Balsera C, Wallace E, Khairullah Q, Lesher B, Gao X, Henderson H, LaFleur P, Delgado EM, Alvarez MM, Hartley J, McClernon M, Walton S, Guest S. PMID: 25526471; PMCID: PMC4603112.
View in:
PubMed Mentions:
21 Fields:
Translation:
Humans
-
Infrastructure requirements for an urgent-start peritoneal dialysis program. Perit Dial Int. 2013 Nov-Dec; 33(6):611-7.
Ghaffari A, Kumar V, Guest S. PMID: 24335123; PMCID: PMC3862090.
View in:
PubMed Mentions:
20 Fields:
Translation:
Humans
-
PD First: peritoneal dialysis as the default transition to dialysis therapy. Semin Dial. 2013 Nov-Dec; 26(6):706-13.
Ghaffari A, Kalantar-Zadeh K, Lee J, Maddux F, Moran J, Nissenson A. PMID: 24102745.
View in:
PubMed Mentions:
28 Fields:
Translation:
Humans
-
A reason for choosing peritoneal dialysis: lessons after the Japan earthquake and the Fukushima nuclear accident. Am J Kidney Dis. 2012 Aug; 60(2):327; author reply 327.
Kimura K, Ogura M, Yokoyama K, Hosoya T. PMID: 22672855.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Intermittent peritoneal dialysis: urea kinetic modeling and implications of residual kidney function. Perit Dial Int. 2012 Mar-Apr; 32(2):142-8.
Guest S, Akonur A, Ghaffari A, Sloand J, Leypoldt JK. PMID: 22135316; PMCID: PMC3525398.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Urgent-start peritoneal dialysis: a quality improvement report. Am J Kidney Dis. 2012 Mar; 59(3):400-8.
Ghaffari A. PMID: 22019332.
View in:
PubMed Mentions:
51 Fields:
Translation:
Humans
-
Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol. 2010; 31(5):419-25.
Shantouf RS, Budoff MJ, Ahmadi N, Ghaffari A, Flores F, Gopal A, Noori N, Jing J, Kovesdy CP, Kalantar-Zadeh K. PMID: 20389057; PMCID: PMC2883846.
View in:
PubMed Mentions:
59 Fields:
Translation:
Humans
-
Determination of carbamylated hemoglobin by an enzyme immunoassay (ELISA) based on a novel antibody. Clin Chim Acta. 2008 May; 391(1-2):112-4.
Singh AK, Gudehithlu KP, Sam R, Arruda JA, Dunea G, Gaffari A, Sethupathi P. PMID: 18307985.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimals
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs